SCHEMBL6404660

SCHEMBL6404660

N=C(NNC(=O)c1cc2cc(Cl)ccc2[nH]1)c1ccccn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PYGL P06737 3/20 0.53
NHERF1 O14745 3/20 0.52
BCAT1 P54687 4/20 0.52
GUSB P08236 4/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
TLR7 Q9NYK1 2/20 0.47
F7 P08709 1/20 0.47
F3 P13726 1/20 0.47
RXFP1 Q9HBX9 1/20 0.46
EGFR P00533 1/20 0.46
PRKD3 O94806 1/20 0.46
PRKCG P05129 1/20 0.46
PRKCB P05771 1/20 0.46
IL1R1 P14778 1/20 0.46
PRKCA P17252 1/20 0.46
TNFRSF1A P19438 1/20 0.46
PRKCH P24723 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6406524 0.92 PYGL (0.58) PYGLNHERF1BCAT1GUSBMEN1
SCHEMBL6399555 0.86 IDO1 (0.47) PYGLNHERF1BCAT1MEN1KMT2A
SCHEMBL6399934 0.82 MEN1 (0.64) PYGLNHERF1BCAT1GUSBMEN1
Hydrochloric Acid SCHEMBL6400052 0.81 MEN1 (0.62) PYGLNHERF1BCAT1GUSBMEN1
SCHEMBL6401150 0.81 NHERF1 (0.61) PYGLNHERF1BCAT1GUSBMEN1
SCHEMBL6399994 0.80 NHERF1 (0.58) PYGLNHERF1BCAT1GUSBMEN1
Hydrochloric Acid SCHEMBL6399705 0.80 NHERF1 (0.60) PYGLNHERF1BCAT1GUSBMEN1
SCHEMBL6401667 0.79 NHERF1 (0.58) PYGLNHERF1BCAT1GUSBMEN1
SCHEMBL6400560 0.79 NHERF1 (0.58) PYGLNHERF1BCAT1GUSBMEN1
SCHEMBL6406739 0.79 BCAT1 (0.62) PYGLNHERF1BCAT1GUSBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050054696-A1 Indole compounds and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-10 US claimed
EP-1452526-A1 INDOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 EP claimed
US-20050054696-A1 Indole compounds and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-10 US disclosed
EP-1452526-A1 INDOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054696-A1 Indole compounds and medicinal use thereof IDO1, GPR119, SLC5A1 PYGL 96/4885NHERF1 332/4885BCAT1 854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.